Clinical Trial 51847

Bellflower, CA 90706


CenExel CIT is currently enrolling in an inpatient schizophrenia study. "A Placebo-controlled Trial of 15 and 30 mg QD Doses of CVL-231 in Participants With Schizophrenia Experiencing an Acute Exacerbation of Psychosis"

  • 18 - 65 Years Old
  • Diagnosis of Schizophrenia at least 1 year.
  • Insurance is not required to qualify.
  • Currently experiencing symptoms of schizophrenia

Qualified Participants May Receive:

  • Compensation for each visit and study-related treatment. 
  • Investigational medications at no cost.

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.